Israel Englander Adamis Pharmaceuticals Corp Transaction History

Millennium Management LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.55 - $0.73 $76,266 - $101,226	-138,666 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.57 - $1.23 $238,539 - $514,743	-418,491 Reduced 75.11%	138,666 $84,000
Q3 2021 Nov 15, 2021	BUY	$0.92 - $1.18 $498,143 - $638,922	541,460 Added 3449.45%	557,157 $540,000
Q2 2021 Aug 16, 2021	SELL	$0.66 - $1.23 $263,236 - $490,576	-398,843 Reduced 96.21%	15,697 $17,000
Q1 2021 May 17, 2021	BUY	$0.54 - $1.79 $223,851 - $742,026	414,540 New	414,540 $390,000
Q4 2020 Feb 16, 2021	SELL	$0.4 - $1.01 $8,006 - $20,217	-20,017 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$0.52 - $1.45 $21,119 - $58,891	-40,615 Reduced 66.99%	20,017 $16,000
Q2 2020 Aug 14, 2020	BUY	$0.33 - $0.66 $2,098 - $4,196	6,359 Added 11.72%	60,632 $33,000
Q1 2020 May 14, 2020	BUY	$0.33 - $0.89 $17,910 - $48,302	54,273 New	54,273 $19,000
Q4 2019 Feb 14, 2020	SELL	$0.51 - $1.26 $14,221 - $35,135	-27,885 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$0.7 - $1.46 $19,519 - $40,712	27,885 New	27,885 $19,000
Q2 2019 Aug 14, 2019	SELL	$1.26 - $2.23 $116,078 - $205,440	-92,126 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$2.02 - $3.22 $186,094 - $296,645	92,126 New	92,126 $194,000
Q2 2018 Aug 14, 2018	SELL	$3.2 - $4.7 $138,080 - $202,805	-43,150 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$2.55 - $4.85 $84 - $160	33 Added 0.08%	43,150 $151,000
Q4 2017 Feb 14, 2018	BUY	$3.5 - $5.65 $49,059 - $79,196	14,017 Added 48.17%	43,117 $190,000
Q3 2017 Nov 14, 2017	BUY	$4.5 - $5.65 $130,950 - $164,415	29,100	29,100 $152,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.